Leucine CEO and co-founder Vivek Gera Leucine Pharmaceutical businesses are high-tech enterprises that develop and distribute drugs at the cutting edge of innovation. However, one area of their business remains remarkably old-fashioned – the compliance work that goes into drug manufacturing remains manual and paper-based, exposing pharma companies to regulatory risk and excessive cost. New York-based Leucine, which is today unveiling a $7 million Series A funding round, sees this as an opportunity. “We set out to build an easy-to-use digital platform that had built-in compliance guidelines and process interlocks to enable compliance by design,” says Vivek Gera, CEO and co-founder of the c
Hence then, the article about how leucine aims to help pharma companies cut compliance costs was published today ( ) and is available onTOP world News today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( How Leucine Aims To Help Pharma Companies Cut Compliance Costs )